This issue remains a subject of active investigation.
49 The study also provided a substantial range and variation in game offerings, addressing the known issue of active games being less engaging, 49 although it was difficult at times to keep participants engaged as the most popular game genre killing was excluded from the study on ethical grounds.
If we consider population ageing on an individual level as a chronological development that ought to be associated with an active way of life of people as they grow old, we encounter the issue of active ageing.
On the essential issue of active Iraqi cooperation in the disclosure and destruction of prohibited unconventional weapons, the inspectors could find little encouraging to say.
Given the certainty of increase in both projected number and share of elderly population, the issue of active ageing will undoubtedly emerge as one of the central strategic cornerstones in both countries.
That said, wherever we come down on the moral issue of Active SETI, we should be cautious to avoid romanticized imaginings about biological or cultural evolution as involving progress.
These findings necessitate serious thought on the issue of active screening for LTBI and subsequent Isoniazid Prophylactic Therapy (IPT), as opposed to passive case detection.
The latest crystal structure of the precleavage HDV ribozyme solves the issue of active-site perturbation through the C75U mutation by inhibiting substrate cleavage through deoxynucleotide mutations on the substrate strand.
Dr. DiBiaggio, 68, says he plans to continue his work "promoting issues of active citizenship".
In just the same way, then, when the body is turbulent and surfeited and burdened with improper food, the lustre and light of the soul inevitably come through it blurred and confused, aberrant and inconstant, since the soul lacks the brilliance and intensity to penetrate to the minute and obscure issues of active life.
This special focus series of commentaries is intended to evaluate the technological and developmental issues of active cancer immunotherapies and will examine and possibly help interpret the enormous number of failures over the last decade, given that there has been only one regulatory success (Dendreon's Provenge for prostate cancer).
